Kytopen Corp

Kytopen Corp, based in Cambridge, MA, is dedicated to enhancing patient access to next-generation living medicines through innovative genome engineering platforms. Their non-viral gene delivery technology addresses cell therapy manufacturing challenges, streamlining drug discovery and optimization processes.

The company's flagship Flowfect platform combines continuous fluid flow and electric fields to deliver payloads efficiently to billions of cells within minutes, enabling scalable cell engineering from the discovery stage to large-volume production. By facilitating high-throughput experimentation and predictive scaling, Kytopen empowers researchers to optimize gene delivery while retaining cell functionality.

Generated from the website